Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,057,446
+$1,703,656 QoQ
Shares Held
31,216
+460.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,452 | $3,701,631 | |
| 2 | INCY |
Incyte Corp
|
23,563 | $2,671,101 | |
| 3 | INSM |
INSMED Inc
|
16,847 | $1,796,227 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,073 | $1,086,350 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,390 | $585,000 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
24,477 | $356,629 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
22,841 | $350,837 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
5,218 | $314,958 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,057,446 | 31,216 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $353,790 | 5,568 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | $949,396 | 17,523 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $746,881 | 10,653 | Shares | Sole | 2024-05-14 | |
| 2020-06-30 | $1,093,930 | 46,412 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $234,137 | 19,859 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||